Biotech stocks down at noon
Wednesday, 11 March, 2009
At 12:30pm the pharmaceuticals index was down 1.3%, bucking the positive overall trend on the ASX which was up almost 2% after big rises on Wall Street overnight.
Index heavyweight CSL (ASX:CSL) accounted for the bulk of the slippage with a drop of 77c to $34.68.
Prana Biotechnology (ASX:PBT) moved up 1.5c, or over 9%, to 17.5c.
Novogen (ASX:NRT) also showed a 6% increase up 2.5c to 45c from yesterday’s lows.
Sigma Pharmaceuticals (ASX:SIP) was down 1% to 95c in light volume.
Scientists uncover how cancer cells hide from immune system
By targeting the RNA helicase known as DDX6, scientists could enable the immune system to...
Vanillin flavouring in vapes may disrupt embryo development
Vanillin — a common flavouring chemical in e-cigarettes — may disrupt the normal...
Heart valve tissues created from stem cells
The breakthrough should help advance our understanding into how human heart valves develop,...
